Aetna Company Profile (NYSE:AET)

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web: www.aetna.com
Capitalization:
  • Market Cap: $53.35063 billion
  • Outstanding Shares: 332,100,000
Average Prices:
  • 50 Day Moving Avg: $158.32
  • 200 Day Moving Avg: $150.48
  • 52 Week Range: $104.59 - $164.52
P/E:
  • Trailing P/E Ratio: 35.84
  • Foreward P/E Ratio: 15.89
  • P/E Growth: 1.75
Sales & Book Value:
  • Annual Revenue: $62.2 billion
  • Price / Sales: 0.86
  • Book Value: $46.38 per share
  • Price / Book: 3.48
Dividend:
  • Annual Dividend: $2.00
  • Dividend Yield: 1.2%
Profitability:
  • EBITDA: $6.06 billion
  • Net Margins: 2.52%
  • Return on Equity: 20.52%
  • Return on Assets: 5.35%
Debt:
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 0.48%
  • Quick Ratio: 0.48%
Misc:
  • Average Volume: 1.81 million shs.
  • Beta: 0.53
  • Short Ratio: 3.37
 

Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna declared a quarterly dividend on Friday, September 29th. Investors of record on Thursday, October 12th will be paid a dividend of $0.50 per share on Friday, October 27th. This represents a $2.00 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date is Wednesday, October 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its board has authorized a share repurchase plan on Friday, April 7th 2017, which permits the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 98% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's leadership believes its stock is undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) announced its quarterly earnings data on Thursday, August, 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. The firm earned $15.52 billion during the quarter, compared to analysts' expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company's quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter last year, the business earned $2.21 earnings per share. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $9.45-9.55 for the period, compared to the Thomson Reuters consensus estimate of $8.99.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

19 brokers have issued 1-year price objectives for Aetna's stock. Their predictions range from $132.00 to $185.00. On average, they anticipate Aetna's stock price to reach $163.69 in the next year. View Analyst Ratings for Aetna.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna’s shares outperformed the industry year to date. We expect the company to derive long-term growth from its Government business. Cost-reduction initiatives and growing ACO collaborations pave the way for long-term growth. A strong balance sheet is another positive. Its International expansion is also perceived as an opportunity in the face of increased regulation in the U.S. Following strong second-quarter results, Aetna rasied its earnings guidance which cements investors' confidence in the company. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 6.3% upward over the last 90 days. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (10/16/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
  • 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
  • Karen S. Lynch, President
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
  • Francis S. Soistman Jr., Executive Vice President - Government Services
  • Sharon Virag, Chief Accounting Officer, Vice President, Controller
  • Edward J. Ludwig, Lead Independent Director

Who owns Aetna stock?

Aetna's stock is owned by a number of of retail and institutional investors. Top institutional investors include Diamond Hill Capital Management Inc. (0.49%), Focused Investors LLC (0.20%), PGGM Investments (0.20%), Strs Ohio (0.14%), APG Asset Management N.V. (0.10%) and Nationwide Fund Advisors (0.07%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., PGGM Investments, Focused Investors LLC, State Treasurer State of Michigan, Eqis Capital Management Inc., Wealth Enhancement Advisory Services LLC, Nationwide Fund Advisors and Fox Run Management L.L.C.. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including Strs Ohio, Shell Asset Management Co., Assenagon Asset Management S.A., Meeder Asset Management Inc., Northpointe Capital LLC, Robeco Institutional Asset Management B.V., Personal Capital Advisors Corp and Quantitative Systematic Strategies LLC. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $161.47.


MarketBeat Community Rating for Aetna (NYSE AET)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  662 (Vote Outperform)
Underperform Votes:  415 (Vote Underperform)
Total Votes:  1,077
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.68)
Consensus Price Target: $163.69 (1.37% upside)
Consensus Price Target History for Aetna (NYSE:AET)
Price Target History for Aetna (NYSE:AET)
Analysts' Ratings History for Aetna (NYSE:AET)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/23/2017Cantor FitzgeraldReiterated RatingBuy$175.00N/AView Rating Details
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$175.00N/AView Rating Details
10/13/2017Jefferies Group LLCBoost Price TargetHold$163.00 -> $165.00N/AView Rating Details
9/12/2017ArgusReiterated RatingBuy$165.00 -> $185.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 -> $179.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank Of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 -> $165.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$180.00LowView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00N/AView Rating Details
(Data available from 10/24/2015 forward)

Earnings

Earnings History for Aetna (NYSE:AET)
Earnings by Quarter for Aetna (NYSE:AET)
Earnings History by Quarter for Aetna (NYSE AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$2.07N/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.34
2018 EPS Consensus Estimate: $10.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.08$2.42$2.17
Q4 20174$1.26$1.74$1.49
Q1 20181$2.76$2.76$2.76
Q2 20181$2.72$2.72$2.72
Q3 20181$2.70$2.70$2.70
Q4 20181$1.84$1.84$1.84
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Aetna (NYSE:AET)
Next Dividend:10/27/2017
Annual Dividend:$2.00
Dividend Yield:1.24%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:43.67% (Trailing 12 Months of Earnings)
20.94% (Based on This Year's Estimates)
19.69% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/29/2017quarterly$0.501.25%10/11/201710/12/201710/27/2017
5/19/2017quarterly$0.501.42%7/11/20177/13/20177/28/2017
2/17/2017quarterly$0.501.58%4/11/20174/13/20174/28/2017
12/2/2016quarterly$0.250.77%1/10/20171/12/20171/27/2017
9/30/2016quarterly$0.250.87%10/11/201610/13/201610/28/2016
5/20/2016quarterly$0.250.91%7/12/20167/14/20167/29/2016
2/19/2016quarterly$0.250.94%4/12/20164/14/20164/29/2016
12/4/2015quarterly$0.250.97%1/12/20161/14/20161/29/2016
9/25/2015quarterly$0.250.95%10/13/201510/15/201510/30/2015
5/15/2015quarterly$0.250.88%7/14/20157/16/20157/31/2015
2/27/2015quarterly$0.251%4/7/20154/9/20154/24/2015
11/21/2014quarterly$0.251.15%1/13/20151/15/20151/30/2015
9/19/2014quarterly$0.231.08%10/14/201410/16/201410/31/2014
5/30/2014quarterly$0.231.16%7/8/20147/10/20147/25/2014
2/28/2014quarterly$0.231.25%4/8/20144/10/20144/25/2014
12/6/2013quarterly$0.231.35%1/14/20141/16/20141/31/2014
9/27/2013quarterly$0.201.25%10/8/201310/10/201310/25/2013
5/17/2013quarterly$0.201.35%7/9/20136/11/20137/26/2013
2/19/2013quarterly$0.201.66%4/9/20134/11/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 89.65%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.61View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.80View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
Source:
Loading headlines, please wait.

Social

Chart

Aetna (AET) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.